The novel dual-mechanism Kv7 potassium channel/TSPO receptor activator GRT-X is more effective than the Kv7 channel opener retigabine in the 6-Hz refractory seizure mouse model-Reference-Cited by-同舟云学术

The novel dual-mechanism Kv7 potassium channel/TSPO receptor activator GRT-X is more effective than the Kv7 channel opener retigabine in the 6-Hz refractory seizure mouse model

Published:2022-02 Issue: Volume:203 Page:108884
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Bloms-Funke Petra,Bankstahl Marion,Bankstahl Jens^ORCID,Kneip Christa,Schröder Wolfgang,Löscher Wolfgang

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference80 articles.

1. N-pyridyl and pyrimidine benzamides as KCNQ2/Q3 potassium channel openers for the treatment of epilepsy;Amato;ACS Med. Chem. Lett.,2011

2. Australian Public Assessment Report for Retigabine;Australian Government,2013

3. Striking differences in proconvulsant-induced alterations of seizure threshold in two rat models;Bankstahl;Neurotoxicology,2012

4. Pilocarpine-induced epilepsy in mice alters seizure thresholds and the efficacy of antiepileptic drugs in the 6-Hertz psychomotor seizure model;Bankstahl;Epilepsy Res.,2013

5. Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine;Barrese;Clin. Pharmacol.,2010

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and genetic analysis of 23 Chinese children with epilepsy associated with KCNQ2 gene mutations;Epilepsia Open;2024-08-14

2. Mitochondrial dysfunction and neurological disorders: A narrative review and treatment overview;Life Sciences;2023-12

3. Replacing the oxidation‐sensitive triaminoaryl chemotype of problematic K _V 7 channel openers: Exploration of a nicotinamide scaffold;Archiv der Pharmazie;2022-11-17

4. Development of an automated screen for Kv7.2 potassium channels and discovery of a new agonist chemotype;Bioorganic & Medicinal Chemistry Letters;2022-09

5. Progress report on new antiepileptic drugs: A summary of the Sixteenth Eilat Conference on New Antiepileptic Drugs and Devices ( EILAT XVI ): I. Drugs in preclinical and early clinical development;Epilepsia;2022-08-09